D. Caput

发表

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

A. Yang, F. McKeon, J. Lélias, 1997, Cell.

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

A. Yang, N. Andrews, M. Fleming, 1998, Molecular cell.

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

Christopher P. Crum, Arlene H. Sharpe, C. Tabin, 1999, Nature.

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

P. Soubrié, P. Ferrara, D. Caput, 1994, FEBS letters.

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

B. Beutler, A. Cerami, D. Caput, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Expression Cloning of an Interferon-inducible 17-kDa Membrane Protein Implicated in the Control of Cell Growth (*)

D. Caput, S. Majjaj, O. Leo, 1995, The Journal of Biological Chemistry.

An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*)

M. Kaghad, P. Ferrara, D. Caput, 1995, The Journal of Biological Chemistry.

Interleukin‐8 production by the human colon epithelial cell line HT‐29: modulation by interleukin‐13

J. Westwick, A. Minty, P. Ferrara, 1996, British journal of pharmacology.

A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.

M. Kaghad, P. Chalon, P. Ferrara, 1992, Journal of immunology.

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.

A. Minty, P. Ferrara, D. Caput, 1995, Blood.

Evidence for Nerve Growth Factor‐Potentiating Activities of the Nonpeptidic Compound SR 57746A in PC12 Cells

P. Ferrara, D. Caput, G. Le Fur, 1995, Journal of neurochemistry.

Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization.

G. I. Bell, D. Caput, G. Bell, 1986, Nucleic acids research.

Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter.

M. Kaghad, D. Caput, D. Fradelizi, 1994, Gene.

Construction of two ordered cDNA libraries enriched in genes encoding plasmalemma and tonoplast proteins from a high-efficiency expression library.

P. Chalon, D. Caput, N. Pauly, 1999, The Plant journal : for cell and molecular biology.

Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α Chain*

J. Lélias, M. Kaghad, P. Ferrara, 1996, The Journal of Biological Chemistry.

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.

J. Lélias, M. Kaghad, P. Ferrara, 1996, The Journal of biological chemistry.

A Novel Human Nicotinic Receptor Subunit, α10, That Confers Functionality to the α9-Subunit

D. Bertrand, D. Caput, N. Walker, 2002 .

Molecular cloning of a human β3‐adrenergic receptor cDNA

J. Lélias, M. Kaghad, P. Chalon, 1993 .

Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.

D. Caput, D. Langin, M. Berlan, 1996, Journal of lipid research.

Interleukin‐13 stimulates interleukin‐6 production by human keratinocytes

P. Casellas, A. Minty, P. Ferrara, 1994, FEBS letters.

Molecular cloning and immunolocalization of two variants of the major basic nuclear protein (HCc) from the histone-less eukaryote Crypthecodinium cohnii (Pyrrhophyta)

D. Caput, G. Vernet, M. Soyer-Gobillard, 1991, Chromosoma.

Purification, cDNA Cloning, and Developmental Expression of the Nodule-Specific Uricase from Phaseolus vulgaris L.

D. Caput, F. Sánchez, F. Campos, 1987, Plant physiology.

Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.

A. Minty, D. Caput, A. Vazquez, 1996, Blood.

Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.

A. Minty, P. Ferrara, D. Caput, 1994, European cytokine network.

Evidence for the presence of β3-adrenergic receptor mRNA in the human brain

P. Ferrara, D. Caput, G. Fur, 1995 .

Inhibition of lysophosphatidic acid-induced neurite retraction and cell rounding by SR 57746A.

P. Ferrara, D. Caput, J. Zachayus, 1998, Brain research. Molecular brain research.

Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ

S. Gordon, L. Montaner, A. Minty, 1994, European journal of immunology.

Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine

A. Minty, P. Ferrara, D. Caput, 1994, The Journal of experimental medicine.

Differential effects of recombinant human interleukin‐13 on the in vitro growth of human haemopoietic progenitor cells

A. Minty, P. Ferrara, D. Caput, 1995, British journal of haematology.

Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production.

S. Bernasconi, A. Minty, P. Ferrara, 1994, Blood.

(cid:1) N -p73 (cid:1) Accumulates in Human Neuroblastic Tumors

M. Kaghad, D. Caput, U. Moll, 2002 .

A. Minty, P. Ferrara, D. Caput, 1997, European cytokine network.

Expression of SKP1 mRNA and protein in rat brain during postnatal development

M. Imbert, C. Fonta, D. Caput, 1997, Neuroreport.

Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats.

A. Minty, P. Ferrara, D. Caput, 1994, Journal of Immunology.

Characterization and Comparison of the Interleukin 13 Receptor with the Interleukin 4 Receptor on Several Cell Types (*)

P. Ferrara, D. Caput, P. Laurent, 1995, The Journal of Biological Chemistry.

Interleukin 13 is a B cell stimulating factor

A. Minty, P. Ferrara, D. Caput, 1994, The Journal of experimental medicine.

IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages.

P. Ferrara, D. Caput, B. Pipy, 1998, Biochimica et biophysica acta.

Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complex

P. Ferrara, D. Caput, P. Laurent, 1997 .

Monocyte Chemotactic Protein 3 Is a Most Effective Basophil-and Eosinophil-activating Chemokine By Clemens

A. Minty, P. Ferrara, D. Caput, 2003 .

IL-13 induces serine phosphorylation of cPLA2 in mouse peritoneal macrophages leading to arachidonic acid and PGE2 production and blocks the zymosan-induced serine phosphorylation of cPLA2 and eicosanoid production.

P. Ferrara, D. Caput, B. Pipy, 1999, Biochimica et biophysica acta.

IL‐13 and IL‐4 share signal transduction elements as well as receptor components in TF‐1 cells

P. Ferrara, D. Caput, N. Vita, 1995, FEBS letters.

Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation.

P. Gaulard, P. Ferrara, D. Caput, 1997, European cytokine network.

Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin‐13

P. Ferrara, D. Caput, F. Quintin-Colonna, 1995, European journal of immunology.

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

P. Ferrara, D. Caput, G. Fur, 1996, Biochimica et biophysica acta.

Interleukin-4 and -13 Inhibit Tumor Necrosis Factor-α mRNA Translational Activation in Lipopolysaccharide-induced Mouse Macrophages*

D. Caput, V. Kruys, G. Huez, 1997, The Journal of Biological Chemistry.

Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex.

P. Ferrara, D. Caput, P. Laurent, 1997, FEBS letters.

The rat β3‐adrenergic receptor gene contains an intron

M. Kaghad, D. Caput, G. Le Fur, 1993 .

Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells

S. Jacobsen, A. Minty, P. Ferrara, 1994, The Journal of experimental medicine.

chronic lymphocytic leukemia B cells from in vitro apoptosis Interleukin-13 inhibits interleukin-2-induced proliferation and protects

A. Minty, D. Caput, A. Vazquez, 2011 .

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

J. Lélias, M. Kaghad, P. Chalon, 1993, FEBS letters.

Interleukin-13 alters mucociliary differentiation of human nasal epithelial cells.

D. Caput, F. Tournier, F. Marano, 2003, Chest.

IL‐4 and IL‐13 have overlapping but distinct effects on HIV production in monocytes

A. Minty, P. Ferrara, D. Caput, 1994, Journal of Leukocyte Biology.

Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step.

P. Ferrara, D. Caput, A. Rahier, 1998, European journal of biochemistry.

Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells.

A. Mantovani, F. Re, A. Minty, 1994, Blood.

Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex

P. Ferrara, D. Caput, P. Laurent, 1997 .

On the shoulders of giants: p63, p73 and the rise of p53.

A. Yang, F. McKeon, M. Kaghad, 2002, Trends in genetics : TIG.

Human interleukin‐13 activates the interleukin‐4‐dependent transcription factor NF‐IL4 sharing a DNA binding motif with an interferon‐γ‐induced nuclear binding factor

E. Rieber, A. Minty, P. Ferrara, 1994, FEBS letters.

Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.

A. Minty, P. Ferrara, D. Caput, 1997, European cytokine network.

A comparison between the synthesis of contractile proteins and the accumulation of their translatable mRNAs during calf myoblast differentiation.

F. Gros, D. Caput, M. Buckingham, 1981, Developmental biology.

Characterization of messenger RNA from embryonic muscle.

F. Gros, D. Caput, D. Luzzati, 1972, Biochimie.

FACTOR VIII GENE SPECIFIC PROBE FOR PRENATAL DIAGNOSIS OF HAEMOPHILIA A

D. Caput, M. Schwartz, K. Hartog, 1985, The Lancet.

ORL1, a novel member of the opioid receptor family

G Vassart, M. Parmentier, P. Chalon, 1994, FEBS letters.

Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA.

S. J. Potter, F. Masiarz, D. Caput, 1985, DNA.

Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes

M. Kirschner, D. Drubin, D. Caput, 1984, The Journal of cell biology.

Studieson the Expressionofthe Microtubule-associated Protein,Tau, duringMouse BrainDevelopment, with Newly IsolatedComplementary DNA Probes

D. Caput, 1984 .

Cloning of human purine-nucleoside phosphorylase cDNA sequences by complementation in Escherichia coli.

S. Williams, D. Caput, D. Martin, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Mutation analysis of P73 and TP53 in Merkel cell carcinoma

F. Speleman, C. Wolf‐Peeters, R. Sciot, 2000, British Journal of Cancer.

MPF from starfish oocytes at first meiotic metaphase is a heterodimer containing one molecule of cdc2 and one molecule of cyclin B.

J. Labbé, J. Cavadore, A. Picard, 1989, The EMBO journal.

Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins

M. Kirschner, D. Caput, Frank D. McKeon, 1986, Nature.

Interleukin-13 Inhibits Protein Kinase C-triggered Respiratory Burst in Human Monocytes

P. Ferrara, D. Caput, C. Cambon, 1995, The Journal of Biological Chemistry.

Expression of p73 and Reelin in the Developing Human Cortex

G. Meyer, D. Caput, H. Ábrahám, 2002, The Journal of Neuroscience.

Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes.

P. Chalon, P. Ferrara, D. Caput, 2001, The Journal of investigative dermatology.

The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor*

M. Kaghad, P. Ferrara, D. Caput, 1998, The Journal of Biological Chemistry.

Molecular cloning of a levocabastine‐sensitive neurotensin binding site

P Ferrara, M. Kaghad, P. Chalon, 1996, FEBS letters.

cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins.

J. Lélias, D. Caput, C. Adra, 1993, Proceedings of the National Academy of Sciences of the United States of America.

lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses

P. Casellas, M. Kaghad, A. Minty, 1993, Nature.

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.

P Ferrara, P. Soubrié, P. Casellas, 1998, European journal of pharmacology.

The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae

M. Kaghad, P. Ferrara, D. Caput, 1996, Molecular and cellular biology.

The synthesis and stability of cytoplasmic messenger RNA during myoblast differentiation in culture.

F. Gros, D. Caput, M. Buckingham, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest

X. Dumont, D. Caput, G. Lenaers, 2000, Yeast.

Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program

M. Kaghad, D. Caput, P. Brachet, 1998, Cell Death and Differentiation.

Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis

M. Kirschner, D. Caput, D. Forbes, 1984, Cell.

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.

M. Kaghad, A. Minty, X. Dumont, 2000, The Journal of biological chemistry.

IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells.

A Coste, O. Houcine, A. Minty, 2001, The Journal of clinical investigation.

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

A. Yang, F. McKeon, R. Bronson, 2000, Nature.

Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73

W. Kaelin, J. Decaprio, D. Caput, 1998, Molecular and Cellular Biology.

Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase.

X. Dumont, P. Ferrara, D. Caput, 1992, The Journal of biological chemistry.

Structural Features of the Central Cannabinoid CB1 Receptor Involved in the Binding of the Specific CB1 Antagonist SR 141716A (*)

Pascual Ferrara, David Shire, M. Kaghad, 1996, The Journal of Biological Chemistry.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers

L. Zelek, M. Mathieu, M. Kaghad, 2000, Oncogene.

Early expression of a β1‐adrenergic receptor and catecholamines in Xenopus oocytes and embryos

D. Caput, L. Paquereau, E. Devic, 1997 .

Early expression of a beta1-adrenergic receptor and catecholamines in Xenopus oocytes and embryos.

D. Caput, L. Paquereau, E. Devic, 1997, FEBS letters.

Bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania tropica: sequence homology with the corresponding monofunctional proteins.

D. Caput, D. Santi, R. Grumont, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and expression of mouse-brain calmodulin as an activator of Bordetella pertussis adenylate cyclase in Escherichia coli.

A. Danchin, P. Chalon, D. Caput, 1989, Gene.

Regulation of Regulatory T Cells

D. Caput, P. Wu, J. Sieper, 1993 .

Nucleoticle sequences of cDNAs α and γ enolase mRNAs from mouse brain

J. Lélias, M. Kaghad, P. Chalon, 1990 .

p73 and p63 Are Homotetramers Capable of Weak Heterotypic Interactions with Each Other but Not with p53*

T. Davison, C. Arrowsmith, M. Kaghad, 1999, The Journal of Biological Chemistry.

Covalent Modification of p73α by SUMO-1

M. Kaghad, A. Minty, X. Dumont, 2000, The Journal of Biological Chemistry.

Identification of TIAR as a Protein Binding to the Translational Regulatory AU-rich Element of Tumor Necrosis Factor α mRNA*

Georges Huez, Cyril Gueydan, P. Chalon, 1999, The Journal of Biological Chemistry.

DeltaN-p73alpha accumulates in human neuroblastic tumors.

M. Kaghad, D. Caput, U. Moll, 2002, The American journal of pathology.

Genomic and allelic expression status of the p73 gene in human neuroblastoma.

D. Caput, M. Barrois, A. Chompret, 2001, Medical and pediatric oncology.

p 73-deficientmicehaveneurological , pheromonal and inflammatory defectsbutlackspontaneoustumours

F. McKeon, R. Bronson, A. Sharpe, 2022 .

p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent

F. McKeon, D. Caput, N. Seki, 1999, Oncogene.

Developmental Roles of p73 in Cajal-Retzius Cells and Cortical Patterning

G. Meyer, D. Caput, N. Walker, 2004, The Journal of Neuroscience.

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro

L. Montaner, A. Minty, P. Ferrara, 1993, The Journal of experimental medicine.

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

M. Kaghad, D. Caput, J. Bosq, 2001, Oncogene.

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

P Ferrara, M. Kaghad, P. Chalon, 1993, FEBS letters.

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

P. Soubrié, P. Ferrara, D. Caput, 2002, Brain Research.

Improved differential screening approach to analyse transcriptional variations in organized cDNA libraries.

M. Kaghad, X. Dumont, P. Ferrara, 1998, Gene.

Primary structure and gene organization of human hepatitis A virus.

S. J. Potter, D. Caput, J. Merryweather, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Chromosomal localization of mouse and human neurotensin receptor genes

M. Mattei, X. Dumont, P. Ferrara, 1994, Mammalian Genome.

Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain.

P. Ferrara, D. Caput, A. Coquerel, 1995, Brain research. Molecular brain research.

[Stimulation of adenylate cyclase by the isoforms of human and rat beta-3 adrenergic receptor expressed in the CHO cells].

D. Caput, M. Lewin, F. Reyl-Desmars, 1995, Gastroenterologie clinique et biologique.

Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor.

M. Mattei, M. Kaghad, X. Dumont, 1991, European journal of biochemistry.

The cell cycle gene SKP1 is regulated by light in postnatal rat brain.

M. Imbert, C. Fonta, D. Caput, 1998, Brain research. Molecular brain research.

IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production.

P. Ferrara, D. Caput, C. Cambon, 1998, Biochemical and biophysical research communications.

Identification of rpaP1-5 and rpaP2-6 genes encoding two additional variants of the 60S acidic ribosomal proteins of Schizosaccharomyces pombe.

D. Caput, G. Lenaers, A. Picard, 2000, Genome.

Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells.

A. Mantovani, F. Re, A. Minty, 1994, The Journal of biological chemistry.

Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.

P Ferrara, P. Ferrara, D. Caput, 1994, Molecular pharmacology.

Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain.

P. Ferrara, D. Caput, N. Walker, 1998, Brain research. Molecular brain research.

The use of a complementary DNA probe to detect accumulation of mengo RNA in infected cells pretreated with interferon.

M. Jacquet, F. Gros, D. Caput, 1977, Biochimie.

Expression and pharmacological characterization of the human peripheral-type benzodiazepine receptor in yeast.

P. Ferrara, D. Caput, G. Fur, 1991, European journal of pharmacology.

A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport.

P. Ferrara, D. Caput, J. Bernassau, 1993, Journal of molecular graphics.

Human Cytomegalovirus Induces Drug Resistance and Alteration of Programmed Cell Death by Accumulation of ΔN-p73α*

D. Caput, S. Allart, C. Détraves, 2002, The Journal of Biological Chemistry.

p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection.

D. Caput, H. Haddada, S. Allart, 2005, Cancer research.

Terrasson J, Allart S, Martin H, Lule J, Haddada H, Caput D et al.. p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection. Cancer Res 65: 2787-2794

D. Caput, H. Haddada, S. Allart, 2005 .

Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha.

D. Caput, S. Allart, C. Détraves, 2002, The Journal of biological chemistry.

CHANGING ROUTE OF CYCLOSPORIN ADMINISTRATION : NEED FOR CLOSE MONITORING

D. Caput, M. Quiroga, K. Hartog, 2003 .

Hepatitis-a-virus vaccine.

S. J. Potter, D. Caput, D. Dina, 1986 .

FACTOR VIII:C SYNTHESIS IN THE KIDNEY

H. D. Anderson, F. Masiarz, D. Caput, 1985, The Lancet.

Molecular cloning of the human type VIII adenylyl cyclase

I. Matsuoka, D. Stengel, J. Hanoune, 1994, FEBS letters.

Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.

F. McKeon, D. Caput, N. Seki, 2001, Medical and pediatric oncology.

A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit.

D. Bertrand, D. Caput, N. Walker, 2002, Molecular Pharmacology.

Molecular basis for the different binding properties of benzodiazepines to human and bovine peripheral‐type benzodiazepine receptors

P. Ferrara, D. Caput, D. Shire, 1993, FEBS letters.

Expression of Human Thymidylate Synthase in

W. Sirawaraporn, D. Caput, D. Santi, 1989 .

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

M. Kaghad, P. Chalon, P. Ferrara, 1993, FEBS letters.

Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes

M. Kirschner, D. Drubin, D. Caput, 1984, The Journal of cell biology.

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

A. Cerami, D. Caput, K. Hartog, 1986, Proceedings of the National Academy of Sciences of the United States of America.

New sequences of nucleic acids of the family suppressor factors tumors, corresponding expression products and their applications

P. Ferrara, D. Caput, Ahmed Mourad Kaghad, 1996 .